Ümit ÖZYURDA, Adnan UYSALEL, Kemalettin UÇANOK, Zeynep B EYİLETEN, A.Ruchan AKAR, Mustafa Bahadır İNAN, Sadık ERYILMAZ, Mustafa ŞIRLAK, Levent YAZICIOĞLU

Prophylactic amiodarone administration before ıntraoperative radiofrequency ablation

Giriş: Bu çalışma, profilaktik amiodaron tedavisinin intraoperatif radyofrekans ablasyonunun so- nuçları üzerine etkisini değerlendirmek amacıyla planlandı.Hastalar ve Yöntem: İntraoperatif radyofrekans ablasyonu uygulanmak üzere seçilen 80 hasta buçalışmaya katıldı ve bu hastalar 2 gruba randomize edildi: ilk grup operasyondan önce 24 saat sü- reyle 30mg/saat amiodaron alırken, 2. gruba plasebo verildi. Klinik çıktılara ek olarak kalp hızları vekalp ritmi hastanede kalım süresince ve 1. ayın sonunda kaydedildi.Bulgular: Demografik ve kardiyak bulgular her iki grupta da benzerdi. Her ne kadar hastaneyeyatırılma sırasındaki kalp hızları benzerse de (102,07±16,04 amiodaron grubu için ve 99,17±17,23kontrol grubu için, p=0,477), anestezi indiksüyonu (83,17±11,77, p

İntraoperatif radyofrekans ablasyon öncesi profilaktik amiodaron uygulaması

Objectives: This study was designed to evaluate the effects of prophylactic amiodarone infusion onthe outcomes of intraoperative radiofrequency ablation.Design: Eighty patients who were scheduled for intraoperative radiofrequency ablation wereenrolled in this study and randomized into two groups: first group received 30mg/h amiodarone24 hours before the operation, and the second group received placebo. Heart rates and cardiacrhythms in addition to clinical outcomes were measured during hospitalization and at the end ofthe 1stmonth. Results: The demographic and cardiac data were similar in both groups. Although the heart ratesat the time of admission were similar between groups (102,07±16,04 for amiodarone group and99,17±17,23 for control group, p=0,477), they were significantly lower in the amiodarone group atthe time of anesthesia induction (83,17±11,77, p

PDF

___

Ostrander LD, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural com- munity, Tecumseh, Michigan. Circulation 1965; 31: 888-898.
Ruchat P, Dang L, Schlaepfer J, et al. Use of a biophysical model of atrial fibrillation in the interpretation of the outcome of surgi- cal ablation procedures. European Journal of Cardio-thoracic Surgery 2007; 32: 90-95.
Chua LY, Schaff HV, Orszulak TA, et al. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. J Thorac Cardiovasc Surg 1994; 107(2): 408-415.
Brodel GK, Cosgrove D, Schiavone W, et al. Cardiac rhythm and conduction disturbanc- es in patients undergoing mitral valve sur- gery. Cleve Clin J Med 1991; 58: 397-399.
Large SR, Hosseinpour AR, Wisbey C, et al. Spontaneous cardioversion and mitral valve repair: a role for surgical cardioversion (Cox- maze)? Eur J Cardio-thorac Surg 1997: 11; 76-80.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent`risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
Cox JL, Schuessler RB, DAgostino HJ Jr, et al. The surgical treatment of atrial fibril- lation. (III) Development of a definitive sur- gical procedure. J Thorac Cardiovasc Surg 1991; 101: 569-583.
Handa N, Schaff HV, Morris JJ, et al. Out- come of valve repair and the Cox maze pro- cedure for mitral regurgitation and associ- ated atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118: 626-635.
Cox JL, Schuessler RB, Lappas DG, et al. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg 1996; 224: 267-273.
Isobe F , Kawashima Y. The outcome and in- dications of the Cox maze III procedure for chronic atrial fibrillation with mitral valve disease. J Thorac Cardiovasc Surg 1998; 116: 220-227.
Izumoto H, Kawazoe K, Eishi K, et al. Me- dium-term results after the modified Cox/ Maze procedure combined with other car- diac surgery. Eur J Cardiothorac Surg 2000; 17: 25-29. Cox JL, Ad N, Palazzo T, et al. The Maze-III procedure combined with valve surgery. Se- min Thorac Thorac Cardiovasc Surg 2000; 12: 53-55.
Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure for atrial fibril- lation: long-term efficacy in patients under- going lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126: 1822- 1828.
Doty DB. Surgical treatment of atrial fibril- lation. Heart Lung Circ. 2004; 13: 280-287.
Kim KC, Cho KR, Kim YJ, et al. Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year expe- rience. Eur J Cardiothorac Surg 2007 Feb; 31(2): 261-266.
Chiappini B, Martin-Suarez S, LoForte A, et al. Cox/Maze III operation versus radiofre- quency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg. 2004; 77: 87-92
Haïssaguerre M, Gencel L, Fischer B, et al. . Successful catheter ablation of atrial fibril- lation. J Cardiovasc Electrophysiol 1994; 5: 1045-1052.
Melo J, Adragão P, Neves J, et al. Surgery for atrial fibrillation using radiofrequency cathe- ter ablation assessment of results at one year. Eur J Cardiothorac Surg 1999; 15: 851-855.
Benussi S, Pappone C, Nascimbene S, et al. A simple way to treat chronic atrial fibrilla- tion during mitral valve surgery: the epicar- dial radiofrequency approach. Eur J Cardio- thorac Surg 2000 17: 524-529
Walther T, Falk V, Walther C, et al. Com- bined stentless mitral valve implantation and radiofrequency ablation. Ann Thorac Surg 2000; 70: 1080-1082.
Fuster V, Rydén LE, Cannom DS, et al. American College of Cardiology; American Heart Association Task Force; European So- ciety of Cardiology Committee for Practice Guidelines; European Heart Rhythm Asso- ciation; Heart Rhythm Society. ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiol- ogy/American Heart Association Task Force on practice guidelines and the European So- ciety of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006; 8: 651-745.
Yiu KH, Lau CP , Lee KL, et al. Emerging energy sources for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2006; 17 Suppl 3: 56-61.
Molloy TA. Midterm clinical experience with microwave surgical ablation of atrial fi- brillation. Ann Thorac Surg 2005; 79: 2115- 2118.
Mack CA, Milla F, Ko W, et al. Surgical treatment of atrial fibrillation using argon- based cryoablation during concomitant car- diac procedures. Circulation. 2005; 112 9 Suppl: I1-6.
Benussi S, Nascimbene S, Calori G, et al. Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device. J Tho- rac Cardiovasc Surg 2005; 130: 491-497.
Kerstein J, Soodan A, Qamar M, et al. Giv- ing IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest. 2004 Sep;126(3):716-24.
Mitchell LB, Wyse DG, Gillis AM, et al. Electropharmacology of amiodarone thera- py initiation: time courses of onset of elec- trophysiologic and antiarrhythmic effects. Circulation 1989;80:34-42
Hauser TH, Pinto DS, Josephson ME, et al. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flut- ter. Am J Cardiol 2004;93:1173-6.